QuidelOrtho
Runs hospital lab instruments and point-of-care rapid tests under one roof.
$14.70
After-hours close−0.04 (−0.27%)
At close$14.74(−3.79%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 125.38%Insiders 0.79%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 68.19M · Float 67.38M · 98.8% free float
Institutions13F, as of Jun 30, 2026
255 holders · 85.50M shares · 58 new positions · 146 increased · 66 reduced · 52 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 11.20M | 16.43% | +753.4K | Aug 7, 2026 |
| FMR LLC | 7.36M | 10.80% | +772.5K | Aug 13, 2026 |
| Newtyn Management, LLC | 6.63M | 9.72% | +2.07M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 4.14M | 6.06% | +103.7K | Aug 13, 2026 |
| Neuberger Berman Group LLC | 3.53M | 5.18% | +2.00M | Aug 13, 2026 |
| Invesco Ltd. | 3.47M | 5.09% | +356.0K | Aug 14, 2026 |
| American Century Companies Inc | 3.31M | 4.85% | +450.9K | Aug 12, 2026 |
| Rubric Capital Management LP | 3.31M | 4.85% | 0 | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.80% | 10.00M | 13G | Jul 17, 2025 ↗ |
| FMR LLC | 11.50% | 7.85M | 13G | May 7, 2026 ↗ |
| T. Rowe Price Investment Management, Inc. | 8.30% | 5.63M | 13G | Apr 8, 2026 ↗ |
| Newtyn Management, LLC | 6.70% | 4.56M | 13G | May 6, 2026 ↗ |
| Capital Management LPincl. Rosen | 6.25% | 4.20M | 13G | Nov 13, 2024 ↗ |
| Vanguard Portfolio Management | 6.00% | 4.09M | 13G | Apr 29, 2026 ↗ |
| Rubric Capital Management LP | 5.56% | 3.78M | 13G | Feb 13, 2026 ↗ |
| Vanguard Capital Management | 5.24% | 3.57M | 13G | Apr 30, 2026 ↗ |
| Neuberger Berman Group LLC | 5.20% | 3.53M | 13G | Jul 8, 2026 ↗ |
| Invesco Ltd. | 5.10% | 3.47M | 13G | Aug 13, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Kenneth F. Buechler | director | 110.4K | 0.16% | Jun 9, 2026 |
| Brian J. Blaser | officer: President and CEO | 75.7K | 0.11% | May 19, 2026 |
| Joseph M. Busky | officer: Chief Financial Officer | 55.1K | 0.08% | Mar 31, 2026 |
| Kenneth J. Widder | director | 44.8K | 0.07% | Jun 9, 2026 |
| Michelle A. Hodges | officer: Chief Legal Officer | 41.6K | 0.06% | Feb 10, 2026 |
| Matthew Strobeck | director | 34.6K | 0.05% | Jun 2, 2026 |
| Edward L. Michael | director | 29.1K | 0.04% | Jun 9, 2026 |
| Ann D. Rhoads | director | 23.3K | 0.03% | Jun 2, 2026 |
| Philip D. McLellan | officer: Chief Operations Officer | 22.5K | 0.03% | Apr 28, 2026 |
| Mary Lake Ph D. Polan | director | 20.2K | 0.03% | Jun 9, 2026 |
35 people have not refiled in the last 18 months (4.57M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 13, 2026 | Brian J. Blaserofficer: President and CEO | Purchase | 10,540 | $23.59 | 40,073 |
| Feb 13, 2026 | Joseph M. Buskyofficer: Chief Financial Officer | Purchase | 3,370 | $23.66 | 10,290 |
| Feb 13, 2026 | Matthew Strobeckdirector | Purchase | 10,000 | $23.96 | 27,775 |
| Dec 10, 2025 | Ann D. Rhoadsdirector | Purchase | 750 | $28.28 | 15,021 |
| Nov 26, 2025 | Joseph D. Jr. Wilkinsdirector | Purchase | 370 | $27.96 | 11,876 |
| Nov 24, 2025 | Joseph M. Buskyofficer: Chief Financial Officer | Purchase | 4,770 | $26.06 | 6,920 |
| Nov 25, 2025 | Kenneth J. Widderdirector | Sale | 4,026 | $27.81 | 37,061 |
| Nov 21, 2025 | Mary Lake Ph D. Polandirector | Purchase | 1,000 | $22.43 | 12,640 |
| Nov 19, 2025 | Brian J. Blaserofficer: President and CEO | Purchase | 23,500 | $21.34 | 29,533 |
CongressHouse and Senate disclosures
Not reported.